Cargando…
Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations
INTRODUCTION: COPD places a huge clinical and economic burden on the US health care system, with acute exacerbations representing a key driver of direct medical costs. Current treatments, although effective in reducing symptoms and limiting exacerbations, do not adequately target the underlying dise...
Autores principales: | Khoudigian-Sinani, Shoghag, Kowal, Stacey, Suggett, Jason A, Coppolo, Dominic P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655131/ https://www.ncbi.nlm.nih.gov/pubmed/29089755 http://dx.doi.org/10.2147/COPD.S143334 |
Ejemplares similares
-
Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika(®) and Acapella(®) Devices
por: Tse, Jenny, et al.
Publicado: (2020) -
Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2019) -
Corrigendum to “Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada”
por: Thanh, Nguyen Xuan, et al.
Publicado: (2019) -
A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients
por: Burudpakdee, Chakkarin, et al.
Publicado: (2018) -
Non-Pharmaceutical Techniques for Obstructive Airway Clearance Focusing on the Role of Oscillating Positive Expiratory Pressure (OPEP): A Narrative Review
por: Coppolo, Dominic P., et al.
Publicado: (2021)